Imbria Pharmaceuticals

Recent Finacing

Series B ext

Recent Raise

Undisclosed

Imbria Pharmaceuticals is a Boston-based clinical-stage biotech developing therapeutics that enhance cardiac energy metabolism for serious cardiovascular diseases.

Massachusetts, United States

1-10

Private

imbria.com